Skip to main content
Richard Malley, MD, Pediatric Infectious Disease, Boston, MA

RichardMalleyMD

Pediatric Infectious Disease Boston, MA

Associate Professor of Pediatrics, Boston Children's Hospital

Are you Dr. Malley?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 40 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    300 Longwood Ave
    Children's Hospital Enders 861.3
    Boston, MA 02115
    Phone+1 617-919-2900

Summary

  • Dr. Richard Malley, MD is a pediatric infectious disease specialist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and Florida. He is affiliated with Boston Children's Hospital and Brigham and Women's Hospital.

Education & Training

  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1990 - 1993
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1990

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1993 - 2025
  • FL State Medical License
    FL State Medical License 2012 - 2014
  • American Board of Pediatrics Pediatric Infectious Diseases

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2010

Publications & Presentations

PubMed

Authored Content

  • A Vaccine That Stops Covid-19 Won’t Be EnoughAugust 2020

Press Mentions

  • COVID Is Spreading More Now Than in Any Previous Back-to-School Season. 3 Things Parents Can Do
    COVID Is Spreading More Now Than in Any Previous Back-to-School Season. 3 Things Parents Can DoAugust 20th, 2024
  • Monkeypox Vaccine Available for Kids on Case-by-Case Basis, FDA Says
    Monkeypox Vaccine Available for Kids on Case-by-Case Basis, FDA SaysAugust 4th, 2022
  • GSK to Buy Cambridge Vaccine Startup Affinivax for $2.1b, with More Payments Possible
    GSK to Buy Cambridge Vaccine Startup Affinivax for $2.1b, with More Payments PossibleMay 31st, 2022
  • Join now to see all